Current advances in biomarkers for targeted therapy in triple-negative breast cancer
Abstract: Triple-negative breast cancer (TNBC) is a complex heterogeneous disease characterized by the absence of three hallmark receptors: human epidermal growth factor receptor 2, estrogen receptor, and progesterone receptor. Compared to other breast cancer subtypes, TNBC is more aggressive, has a...
Na minha lista:
| Principais autores: | , , |
|---|---|
| Formato: | Revisão |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Acesso em linha: | https://doi.org/10.2147/bctt.s114659 https://www.dovepress.com/getfile.php?fileID=32807 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|